Through 联合研究 by RudaCure's technical team and 嘉泉大学吉医院, a study on MMP9 — which can be used as a biomarker in 干眼症 patients — was published in an academic journal. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7910104/